Delivery Order SPE2DR25D6028-SPE2DR26FARFA
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Dextroamphetamine 5mg tablets (100 count) under a firm fixed-price contract with a ceiling value of $3,760.55 and a completion date of September 8, 2025. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100 tablets. This contract is a firm fixed price delivery order with a ceiling value of $1,436.91 and an ultimate completion date of September 3, 2025. The award carries no set-aside designation and was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100 tablets, with a ceiling value of $1,131.12. This is a firm fixed price delivery order with an ultimate completion date of November 3, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 10 mg tablets (100 count) on September 4, 2025, with a ceiling value of $1,034.62 and completion date of September 5, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg tablets in quantities of 100 units, with a contract ceiling value of $3,857.54. This is a firm fixed-price delivery order with an ultimate completion date of September 10, 2025, and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The work will be performed at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dextroamphetamine 5 mg tablets (100 count) valued at $1,079.86 under a firm fixed price contract type. The award was made on August 28, 2025, with an ultimate completion date of August 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-competitive, non-set-aside purchase issued under AmerisourceBergen's existing contract vehicle...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg tablets (100-count bottles) with a ceiling value of $1,187.03. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Dextroamphetamine-Amphetamine 5 mg tablets in quantities of 100s, with a ceiling value of $4,627.63 and an ultimate completion date of July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 5 mg tablets (100 count) on October 22, 2025, with a ceiling value of $1,046.08 and an ultimate completion date of October 23, 2025. This non-competitive, firm fixed-price delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $1 billion and extends through December...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 5 mg tablets (100 count) valued at $1,107.73 on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FARFADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Dextroamphetamine 5mg tablets (100 count) with a ceiling value of $2,659.93. This is a firm fixed price delivery order with an ultimate completion date of November 4, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. No set-aside designation was used for this competitive award. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a comprehensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's federal contracting demonstrates its capability to serve diverse therapeutic needs across multiple government healthcare customers, including the Defense Health Agency and U.S. Coast Guard, through flexible contract vehicles designed to support global pharmaceutical requirements for defense and military operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 11/3/25 |